SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (3577)4/24/1998 3:39:00 PM
From: Hank  Read Replies (1) of 7041
 
Correction: the statement made by Ferguson in the street.com article referred to the frequency of successful sexual intercourse attempts by men on Vasomax versus Viagra not simply the improvement of erections.
According to the Viagra web page, attempts at intercourse were successful 50% of the time with patients on Viagra according to patient diaries (including the placebo effect). This is equivalent to the type of comparison that Ferguson was referring to. However, Pfizer states that their clinical studies involved men suffering from
varying degrees of ED whereas the studies quoted in the Journal of Urology abstract states that studies on Vasomax were conducting using men suffering from mild or minimal ED. Therefore, the comparison of
successful attempts at sexual intercourse between Vasomax and Viagra is still misleading and imprecise.

I figured I'd better point out my mistake before you or somebody else does. NOW I feel better.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News